Science Explorer Back to mapMap
Discussion
Researcher · Almirall (Spain) · Spain

V. Koscielny

V. Koscielny publishes mostly in Rheumatology, Immunology and Radiology, Nuclear Medicine and Imaging, on topics such as Systemic Lupus Erythematosus Research, Psoriasis: Treatment and Pathogenesis and Monoclonal and Polyclonal Antibodies Research.

OpenAlex
World rank
#4,323,674
of 7,710,434 ranked researchers
Rank in Spain
#99,334
of 204,306
Works
27
Citations
308
Citations per work
11.4
h-index
7
i10-index 6Top 74% in Rheumatology
V. Koscielny

What does V. Koscielny research?

V. Koscielny's work is mostly in Medicine (46%), Immunology and Microbiology (19%), Pharmacology, Toxicology and Pharmaceutics (5%).

Health Sciences: 12 works · 46.0% of their workMedicine: 12 works · 46.0% of their workRheumatology: 5 works · 20.3% of their workRadiology, Nuclear Medicine and Imaging: 3 works · 10.8% of their workDermatology: 2 works · 8.1% of their workPathology and Forensic Medicine: 2 works · 6.8% of their workEverything else: 8 works · 29.7% of their workLife Sciences: 7 works · 24.3% of their workImmunology and Microbiology: 5 works · 18.9% of their workImmunology: 5 works · 18.9% of their workPharmacology, Toxicology and Pharmaceutics: 1 works · 5.4% of their workPharmacology: 1 works · 5.4% of their workTHEIR WORKV. Koscielny27works
Life Sciences24%Health Sciences46%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1246.0%
  2. Everything else829.7%
    1. Immunology and Microbiology518.9%
    2. Pharmacology, Toxicology and Pharmaceutics15.4%
  1. 1Rheumatology20% of their works
  2. 2Immunology19% of their works
  3. 3Radiology, Nuclear Medicine and Imaging11% of their works
  4. 4Dermatology8% of their works
  5. 5Pathology and Forensic Medicine7% of their works
  6. 6Pharmacology5% of their works

Research topics

Which keywords describe V. Koscielny's research?

The keywords of their largest research topics: Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Regulatory T Cells, Fc Receptors, IL-17, TH17 Cells, Therapeutic Antibodies and Inflammation.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Antiphospholipid Syndrome111 topic
  2. Systemic Lupus Erythematosus111 topic
  3. Regulatory T Cells102 topics
  4. Fc Receptors81 topic
  5. IL-1781 topic
  6. TH17 Cells81 topic
  7. Therapeutic Antibodies81 topic
  8. Inflammation73 topics
  9. Cost-effectiveness Analysis41 topic
  10. Quality of Life41 topic
  11. Acne Vulgaris31 topic
  12. Filaggrin31 topic
  13. Rosacea31 topic
  14. Skin Microbiome31 topic
  15. Atherosclerosis21 topic
  16. Glycyrrhizin21 topic
  17. Immune Response21 topic
  18. Licorice21 topic

Where does V. Koscielny work?

V. Koscielny's main affiliation in the publication record is Almirall (Spain), Spain.

How many publications and citations does V. Koscielny have?

OpenAlex counts 27 works and 308 citations for V. Koscielny, an h-index of 7, ranking #4,323,674 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about V. Koscielny. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.